“Complement Inhibition in Rare Kidney Disease: Response Heterogeneity and Biomarker-Guided Withdrawal”. 2025. Translational Medicine & Therapeutics Journal 4 (1): 28-36. https://doi.org/10.5281/zenodo.22649336.